Daily Sepsis Research Analysis
Analyzed 34 papers and selected 3 impactful papers.
Summary
Analyzed 34 papers and selected 3 impactful articles.
Selected Articles
1. Interleukin-6-Associated Pyroptosis, Apoptosis, and Necroptosis via JAKs/STAT3-RIPK1 Axis: A Potential Mechanism for CD4+ T-Cell Depletion in Bacterial Sepsis.
In a prospective sepsis cohort with mechanistic in vitro validation, elevated IL-6 correlated with CD4+ T-cell loss, and PBMC RNA-seq showed activation of IL-6/JAK-STAT3 and cell death programs. IL-6 directly induced PANoptosis in CD4+ T cells via JAK-STAT3–dependent RIPK1-PANoptosome assembly; JAK/STAT3 or RIPK1 inhibition reduced cell death and partially restored function.
Impact: This study provides mechanistic evidence that PANoptosis drives T-cell depletion in sepsis via an IL-6/JAK-STAT3–RIPK1 axis, highlighting druggable nodes that could reverse immunosuppression.
Clinical Implications: Targeting IL-6/JAK-STAT3 or RIPK1 could help preserve CD4+ T-cell viability and function in sepsis, informing trials of JAK inhibitors, anti–IL-6 strategies, or RIPK1 modulators in immunoparalysis.
Key Findings
- CD4+ T-cell counts were significantly reduced in sepsis and septic shock and strongly correlated with elevated IL-6.
- PBMC RNA-seq showed activation of IL-6/JAK-STAT3 signaling and upregulation of apoptosis, pyroptosis, and necroptosis genes.
- IL-6 induced PANoptosis in CD4+ T cells via JAK-STAT3–dependent RIPK1-PANoptosome assembly; JAK/STAT3 or RIPK1 inhibition reduced cell death and improved functional readouts.
Methodological Strengths
- Prospective clinical cohort with multivariate analyses linked to cytokine profiles and immune phenotyping
- Integrated mechanistic validation with RNA-seq and targeted inhibition in primary human CD4+ T cells
Limitations
- Single-center study; causality cannot be definitively established from observational clinical data
- In vitro findings may not fully recapitulate in vivo T-cell dynamics across diverse sepsis etiologies
Future Directions: Test JAK/STAT3 and RIPK1-targeted interventions in early-phase clinical trials focused on reversing sepsis-induced immunoparesis, and stratify by IL-6 levels and PANoptosis biomarkers.
OBJECTIVES: Sepsis triggers both excessive inflammation and immunosuppression, the latter partly characterized by CD4+ T-cell depletion. The mechanisms underlying this depletion, especially its interplay with cytokine storms driven by inflammatory factors such as interleukin (IL)-6, remain unclear. This study aimed to elucidate the molecular mechanisms contributing to CD4+ T-cell depletion in sepsis, focusing specifically on the IL-6/Janus kinases (JAKs)/signal transducer and activator of transcription 3 (STAT3) signaling axis and programmed cell death. DESIGN: Prospective cohort study. SETTING: Adult ICUs at a university hospital. PATIENTS: Adult sepsis and septic shock patients without any documented immune comorbidity. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: A prospective analysis enrolled 151 patients (93 sepsis, 58 septic shock) and 20 controls. Flow cytometry and enzyme-linked immunosorbent assay were used to assess immune cell populations and cytokine profiles, with multivariate analyses exploring their interrelationships. An additional 30 sepsis patients and ten controls were recruited to investigate mechanisms. Peripheral blood mononuclear cells (PBMCs) underwent RNA sequencing (RNA-seq). Isolated CD4+ T cells were stimulated with IL-6 in vitro, followed by treatment with specific inhibitors targeting pyroptosis, apoptosis, necroptosis, the JAKs/STAT3 pathway, or receptor-interacting protein kinase 1 (RIPK1). Western blotting, flow cytometry, immunofluorescence, Cell Counting Kit-8 assays, and interferon-gamma staining evaluated cell death pathways, PANoptosome (a complex mediating apoptosis, pyroptosis and necroptosis)-assembly, and function. Significant CD4+ T-cell loss occurred in both sepsis and septic shock groups, strongly correlating with elevated IL-6 levels. Sepsis PBMC RNA-seq revealed activated IL-6/JAKs/STAT3 signaling and upregulated apoptosis/pyroptosis/necroptosis genes. In vitro, IL-6 induced pyroptosis, apoptosis, and necroptosis (PANoptosis) in CD4+ T cells via IL-6/JAKs/STAT3-dependent RIPK1-PANoptosome assembly. Inhibiting JAKs/STAT3 or RIPK1 significantly reduced PANoptosis, partially restored CD4+ T-cell viability and functional capacity. CONCLUSIONS: PANoptosis has been observed to be a form of CD4+ T-cell death in sepsis patients. Evidence suggests that IL-6 may be associated with the exhaustion process, mechanistically involving the activation of the JAKs/STAT3 pathway. It is also hypothesized that this process might be linked to RIPK1-PANoptosome-mediated PANoptosis.
2. Association of Hypercapnic and Nonrespiratory Acidemia With Hospital Mortality in Mechanically Ventilated Patients With Sepsis: A Retrospective Multicenter Cohort Study.
Across 52,405 ventilated sepsis patients in 201 ICUs over 17 years, compensated hypercapnia, hypercapnic acidemia, and nonrespiratory acidemia in the first 24 hours were each associated with higher hospital mortality versus normal pH/normocapnia. Associations were consistent across diagnostic subgroups.
Impact: This large, binational analysis quantifies acid-base and CO2 derangements as independent mortality risks in ventilated sepsis, informing ventilator strategies and early resuscitation targets.
Clinical Implications: Avoidance of significant acidemia and cautious application of permissive hypercapnia may be prudent in sepsis; early correction of nonrespiratory acidemia and careful ventilator titration could reduce risk.
Key Findings
- Among 52,405 patients, compensated hypercapnia (OR 1.39), hypercapnic acidemia (OR 1.68), and nonrespiratory acidemia (OR 1.75) were each associated with higher hospital mortality versus normal pH/normocapnia.
- Associations persisted across all prespecified diagnostic subgroups; compensated hypercapnia was notably associated with risk in neurologic and unspecified sepsis subgroups.
- Exposures were defined by arterial pH and PaCO2 within the first 24 hours of ICU stay and analyzed using logistic and Cox regression.
Methodological Strengths
- Very large, multicenter binational cohort spanning 17 years and 201 ICUs
- Robust statistical modeling (logistic and Cox regression) with prespecified subgroup analyses
Limitations
- Retrospective design with potential residual confounding and selection bias
- Single time-window exposure (first 24 hours) without granular data on ventilatory strategies or acidemia correction
Future Directions: Prospective interventional trials should test acid-base targets and ventilation strategies in septic patients, stratifying by source of acidemia and monitoring dynamic CO2 trajectories.
OBJECTIVES: The mortality among patients admitted with sepsis remains high and varies depending on the site of infection. The impact of hypercapnia and acidemia on clinical outcomes in mechanically ventilated patients with sepsis is not well understood. DESIGN: Multicenter, binational, retrospective study assessed the association of compensated hypercapnia, hypercapnic acidemia, and nonrespiratory acidemia, in mechanically ventilated patients with mortality in sepsis. SETTING: Data were extracted from the "Australian and New Zealand Intensive Care Society Centre for Outcome and Resource Evaluation adult patient" database over a 17-year period (from January 2006 to December 2022) from 201 ICUs. PATIENTS: Patients were classified into four mutually exclusive groups based on a combination of arterial pH and arterial Co2 recorded during the first 24 hours of ICU stay: normocapnia with normal pH, fully compensated hypercapnia, hypercapnic acidemia, and nonrespiratory acidemia. Logistic regression and Cox proportional hazards regression were used to examine the association of compensated hypercapnia, hypercapnic, and nonrespiratory academia to hospital mortality. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Fifty-two thousand four hundred five patients were included. Overall compensated hypercapnia (odds ratio [OR], 1.39; 95% CI, 1.24-1.55; p < 0.001), hypercapnic acidemia (OR, 1.68; 95% CI, 1.57-1.80; p < 0.001), and nonrespiratory acidemia (OR, 1.75; 95% CI, 1.61-1.90; p < 0.001) was associated with increased risk of hospital mortality as compared with patients with normocapnia and normal pH. The risk of increased hospital mortality associated with hypercapnic and nonrespiratory acidemia persisted in all prespecified diagnostic subgroups when compared with patients who had normal pH and normocapnia. Compensated hypercapnia was associated with increased mortality risk in neurologic and unspecified subgroups of sepsis. CONCLUSIONS: Hypercapnic acidemia and nonrespiratory acidemia within the first 24 hours of ICU admission are associated with increased risk of hospital mortality in mechanically ventilated patients with sepsis. This association remains consistent in all diagnostic subgroups of sepsis.
3. Prevalence, treatment, and outcomes of sepsis during rapid response team calls: A systematic review and meta-analysis.
Across 26 studies (110,909 patients), sepsis accounted for 23.7% of RRT activations, with hospital mortality of 12.9% and median hospital stay of 18 days. Antibiotics were initiated or changed in 38.8% of sepsis-related RRTs, and 23.3% of patients were transferred to ICU.
Impact: By quantifying the burden of sepsis in RRT events, this review highlights system-level opportunities to standardize recognition and escalation, potentially improving outcomes.
Clinical Implications: Hospitals should implement standardized sepsis recognition and escalation protocols within RRT workflows, ensuring rapid antimicrobial initiation and clear ICU transfer criteria.
Key Findings
- Pooled prevalence of sepsis among RRT calls was 23.7% (95% CI 15.5–34.6) across 26 studies.
- Overall hospital mortality among sepsis-related RRT patients was 12.9%, with a pooled hospital length of stay of 18 days.
- Antibiotics were initiated or changed in 38.8% of sepsis-related RRTs; 23.3% of patients were transferred to ICU while most remained on wards.
Methodological Strengths
- PRISMA-guided systematic review with dual independent screening and quality assessment
- Random-effects meta-analysis across multiple international cohorts
Limitations
- Heterogeneity in sepsis definitions, RRT criteria, and hospital practices across studies
- Predominantly observational data limit causal inference; potential publication bias
Future Directions: Prospective, protocolized RRT sepsis pathways with standardized definitions should be tested to determine impact on time to antibiotics, ICU transfer, and mortality.
INTRODUCTION: Sepsis is a leading cause of morbidity and mortality in hospitalised patients. Rapid Response Teams (RRTs) review clinically deteriorating patients, including those with sepsis. However, the epidemiology of sepsis in RRT calls remains unclear. This systematic review synthesised evidence on the prevalence, treatment, and outcomes of sepsis during RRT calls. METHODS: Seven electronic databases (PubMed, Web of Science, Embase, CINAHL, Cochrane Library, Ovid MEDLINE, and Scopus) were searched for studies published from 1 January 2015 to 31 May 2024. All articles were independently screened and assessed for study quality using the Newcastle Ottawa Scale by two reviewers per article. The primary outcome was the prevalence of sepsis during RRT calls. Secondary outcomes included hospital mortality and length of hospitalisation. Data were pooled using random-effects meta-analyses. RESULTS: From 5632 studies screened, 26 studies encompassing 110,909 patients and 139,076 RRT events were included. The pooled mean age was 64.4 years (95%CI: 59.2-69.7) and 48.4 % (n = 51,720, 24 studies) were male. The pooled prevalence of sepsis among all RRT calls was 23.7 % (95%CI: 15.5 %-34.6 %), with no significant difference between studies including exclusively sepsis RRT calls and studies with all causes of RRT calls (32.7 % vs. 21.8 %; p = 0.16). Common sepsis-related RRT triggers included abnormal respiratory and heart rates. Overall hospital mortality was 12.9 % (95%CI: 7.3-21.7 %) and hospital length of stay was 18 days (95%CI: 13.9-22.1), both showing no significant differences between studies including exclusively sepsis RRT calls and studies with all causes of RRT calls. New or changes in antibiotics were initiated in 38.8 % of sepsis-related RRTs. Most patients remained on the ward, while 23.3 % were transferred to the ICU. CONCLUSIONS: Sepsis is a trigger for a quarter of RRT calls, associated with substantial resource use and mortality in one eighth of patients. These findings support the need for standardised recognition protocols, escalation guidelines and prospective trials to optimise outcomes.